Bio-Rad Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0905722072
USD
320.06
-0.28 (-0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
651.60
585.40
667.50
649.73
638.48
610.82
681.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
651.60
585.40
667.50
649.73
638.48
610.82
681.18
Raw Material Cost
306.20
274.80
312.40
293.83
282.76
284.35
315.28
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.60
12.00
12.20
12.17
12.26
12.28
12.36
Selling and Distribution Expenses
205.10
193.50
202.50
200.44
196.12
210.48
205.90
Other Expenses
4.82
4.82
5.56
4.89
4.70
5.17
4.99
Total Expenditure (Excl Depreciation)
572.10
528.50
582.70
555.36
538.18
558.81
583.39
Operating Profit (PBDIT) excl Other Income
79.5
56.900000000000006
84.80000000000001
94.39999999999999
100.3
52
97.8
Other Income
15.10
39.90
21.40
16.44
19.84
36.47
21.14
Operating Profit (PBDIT)
145.20
145.00
155.50
159.91
166.74
136.28
171.94
Interest
12.60
12.00
12.20
12.17
12.26
12.28
12.36
Exceptional Items
332.00
-1.40
-1,002.90
762.99
-2,894.16
414.88
321.82
Gross Profit (PBDT)
345.40
310.60
355.10
355.90
355.72
326.47
365.90
Depreciation
50.60
48.20
49.30
49.10
46.60
47.80
53.00
Profit Before Tax
414.00
83.40
-908.90
861.62
-2,786.28
491.08
428.39
Tax
96.20
19.40
-193.10
208.45
-620.79
107.16
78.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
317.80
64.00
-715.80
653.17
-2,165.49
383.92
349.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
317.80
64.00
-715.80
653.17
-2,165.49
383.92
349.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
317.80
64.00
-715.80
653.17
-2,165.49
383.92
349.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,128.70
6,679.40
6,569.30
7,487.86
6,778.79
9,051.13
8,741.13
Earnings per share (EPS)
11.67
2.29
-25.57
23.34
-76.26
13.45
12.14
Diluted Earnings per share
11.67
2.29
-25.57
23.34
-76.26
13.45
12.14
Operating Profit Margin (Excl OI)
12.2%
9.72%
12.7%
14.52%
15.71%
8.51%
14.36%
Gross Profit Margin
71.3%
22.48%
-128.78%
140.17%
-429.1%
88.22%
70.67%
PAT Margin
48.77%
10.93%
-107.24%
100.53%
-339.16%
62.85%
51.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 11.31% vs -12.30% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 396.56% vs 108.94% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 23.79% vs -21.63% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 5.00% vs -1.64% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Bio-Rad Laboratories, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
651.60
533.54
118.06
22.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
651.60
533.54
118.06
22.13%
Raw Material Cost
306.20
201.07
105.13
52.29%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.60
7.61
4.99
65.57%
Selling and Distribution Expenses
205.10
148.75
56.35
37.88%
Other Expenses
4.82
4.01
0.81
20.20%
Total Expenditure (Excl Depreciation)
572.10
397.57
174.53
43.90%
Operating Profit (PBDIT) excl Other Income
79.50
135.97
-56.47
-41.53%
Other Income
15.10
12.52
2.58
20.61%
Operating Profit (PBDIT)
145.20
197.98
-52.78
-26.66%
Interest
12.60
7.61
4.99
65.57%
Exceptional Items
332.00
-14.07
346.07
2,459.63%
Gross Profit (PBDT)
345.40
332.47
12.93
3.89%
Depreciation
50.60
49.48
1.12
2.26%
Profit Before Tax
414.00
126.82
287.18
226.45%
Tax
96.20
30.57
65.63
214.69%
Provisions and contingencies
0
0
0.00
Profit After Tax
317.80
96.25
221.55
230.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
317.80
96.25
221.55
230.18%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
317.80
96.25
221.55
230.18%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,128.70
3,505.49
3,623.21
103.36%
Earnings per share (EPS)
11.67
0.44
11.23
2,552.27%
Diluted Earnings per share
11.67
0.44
11.23
2,552.27%
Operating Profit Margin (Excl OI)
12.20%
25.49%
0.00
-13.29%
Gross Profit Margin
71.30%
33.04%
0.00
38.26%
PAT Margin
48.77%
18.04%
0.00
30.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 65.16 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.31% vs -12.30% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 2.05% vs -6.25% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 31.78 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 396.56% vs 108.94% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 114.68% vs -86.31% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.01 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 23.79% vs -21.63% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -11.44% vs -6.97% in Jun 2024

Quarterly - Interest
Interest 1.26 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.00% vs -1.64% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 2.44% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.20%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024